'Ketamine' nasal spray approved for treating depression in US

'Ketamine' nasal spray approved for treating depression in US

March 20, 2019

A breakthrough treatment based on the recreational drug ketamine has been approved in the US for people with severe depression.

Esketamine is administered as a nasal spray and was approved by the Food and Drug Administration (FDA) this week after trials showing it could relieve depressive symptoms within hours.

This is unlike regular antidepressants, which can take weeks to work leaving sufferers, who may be contemplating suicide, incredibly vulnerable.

“[That speed] is a huge thing because depressed patients are very disabled and suffer enormously,” said Dr John Mann, a psychiatrist and researcher at Columbia University.

Esketamine is the first approved depression treatment for more than 30 years to act on the brain in a unique way, and will be offered to patients who have tried at least two other treatments without success.

Because of the potential for abuse, esketamine is administered under medical supervision, with patients supervised for two hours afterwards.


Marilyn hanson

Marilyn hanson said:

I suffer from bipolar and depression. I’m game.

Lil Pump

Lil Pump said:



Kayla said:

Yesss good job America


Day said:

I suffer severe depression. I need one

Leave a comment